Cheryl L Brosig1, Laurel Bear2, Sydney Allen3, Raymond G Hoffmann3, Amy Pan3, Michele Frommelt2, Kathleen A Mussatto2. 1. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; Herma Heart Center, Children's Hospital of Wisconsin, Milwaukee, WI. Electronic address: cbrosig@chw.org. 2. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI; Herma Heart Center, Children's Hospital of Wisconsin, Milwaukee, WI. 3. Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Abstract
OBJECTIVE: To describe preschool neurodevelopmental outcomes of children with complex congenital heart disease (CHD), who were evaluated as part of a longitudinal cardiac neurodevelopmental follow-up program, as recommended by the American Heart Association and the American Academy of Pediatrics, and identify predictors of neurodevelopmental outcomes in these children. STUDY DESIGN: Children with CHD meeting the American Heart Association/American Academy of Pediatrics high-risk criteria for neurodevelopmental delay were evaluated at 4-5 years of age. Testing included standardized neuropsychological measures. Parents completed measures of child functioning. Scores were compared by group (single ventricle [1V]; 2 ventricles [2V]; CHD plus known genetic condition) to test norms and classified as: normal (within 1 SD of mean); at risk (1-2 SD from mean); and impaired (>2 SD from mean). RESULTS: Data on 102 patients were analyzed. Neurodevelopmental scores did not differ based on cardiac anatomy (1V vs 2V); both groups scored lower than norms on fine motor and adaptive behavior skills, but were within 1 SD of norms. Patients with genetic conditions scored significantly worse than 1V and 2V groups and test norms on most measures. CONCLUSIONS: Children with CHD and genetic conditions are at greatest neurodevelopmental risk. Deficits in children with CHD without genetic conditions were mild and may not be detected without formal longitudinal testing. Parents and providers need additional education regarding the importance of developmental follow-up for children with CHD.
OBJECTIVE: To describe preschool neurodevelopmental outcomes of children with complex congenital heart disease (CHD), who were evaluated as part of a longitudinal cardiac neurodevelopmental follow-up program, as recommended by the American Heart Association and the American Academy of Pediatrics, and identify predictors of neurodevelopmental outcomes in these children. STUDY DESIGN:Children with CHD meeting the American Heart Association/American Academy of Pediatrics high-risk criteria for neurodevelopmental delay were evaluated at 4-5 years of age. Testing included standardized neuropsychological measures. Parents completed measures of child functioning. Scores were compared by group (single ventricle [1V]; 2 ventricles [2V]; CHD plus known genetic condition) to test norms and classified as: normal (within 1 SD of mean); at risk (1-2 SD from mean); and impaired (>2 SD from mean). RESULTS: Data on 102 patients were analyzed. Neurodevelopmental scores did not differ based on cardiac anatomy (1V vs 2V); both groups scored lower than norms on fine motor and adaptive behavior skills, but were within 1 SD of norms. Patients with genetic conditions scored significantly worse than 1V and 2V groups and test norms on most measures. CONCLUSIONS:Children with CHD and genetic conditions are at greatest neurodevelopmental risk. Deficits in children with CHD without genetic conditions were mild and may not be detected without formal longitudinal testing. Parents and providers need additional education regarding the importance of developmental follow-up for children with CHD.
Authors: Matthew R Reynolds; Caroline Scheiber; Daniel B Hajovsky; Bryanna Schwartz; Alan S Kaufman Journal: J Genet Psychol Date: 2015-07-02 Impact factor: 1.509
Authors: Renée Sananes; Cedric Manlhiot; Edmond Kelly; Lisa K Hornberger; William G Williams; Daune MacGregor; Raymond Buncic; Brian W McCrindle Journal: Ann Thorac Surg Date: 2012-05 Impact factor: 4.330
Authors: J William Gaynor; Richard F Ittenbach; Marsha Gerdes; Judy Bernbaum; Robert R Clancy; Donna M McDonald-McGinn; Elaine H Zackai; Gil Wernovsky; Susan C Nicolson; Thomas L Spray Journal: J Thorac Cardiovasc Surg Date: 2014-01-02 Impact factor: 5.209
Authors: Adam R Cassidy; Matthew T White; David R DeMaso; Jane W Newburger; David C Bellinger Journal: J Int Neuropsychol Soc Date: 2014-12-09 Impact factor: 2.892
Authors: Andrew S Mackie; Shabnam Vatanpour; Gwen Y Alton; Irina A Dinu; Lindsay Ryerson; Diane M Moddemann; Julie Thomas Petrie Journal: Ann Thorac Surg Date: 2015-04-22 Impact factor: 4.330
Authors: Tiffany Riehle-Colarusso; Andrew Autry; Hilda Razzaghi; Coleen A Boyle; William T Mahle; Kim Van Naarden Braun; Adolfo Correa Journal: Pediatrics Date: 2015-08-17 Impact factor: 7.124
Authors: Daniel J Licht; David M Shera; Robert R Clancy; Gil Wernovsky; Lisa M Montenegro; Susan C Nicolson; Robert A Zimmerman; Thomas L Spray; J William Gaynor; Arastoo Vossough Journal: J Thorac Cardiovasc Surg Date: 2009-03 Impact factor: 5.209
Authors: Amy Cassedy; Dennis Drotar; Richard Ittenbach; Shawna Hottinger; Jo Wray; Gil Wernovsky; Jane W Newburger; Lynn Mahony; Kathleen Mussatto; Mitchell I Cohen; Bradley S Marino Journal: Health Qual Life Outcomes Date: 2013-06-18 Impact factor: 3.186
Authors: Martina Brueckner; Mustafa K Khokha; Laura R Ment; Weizhen Ji; Dina Ferdman; Joshua Copel; Dustin Scheinost; Veronika Shabanova Journal: Sci Rep Date: 2020-04-27 Impact factor: 4.379